Decentralized Clinical Trials
PPD DECENTRALIZED CLINICAL TRIALS NETWORK
In an increasingly digital world, decentralized clinical trials (DCTs) have accelerated recruitment, cut trial timelines and removed barriers to reach diverse patient populations. PPD has developed a DCT certification program to support sites in the DCT space, enabling improved quality and delivery of decentralized trials. Our PPD DCT Network will identify investigators/sites with digital and decentralized capabilities and prepare them through an eLearning program created in collaboration with the Society of Clinical Research Sites (SCRS). Watch the video below to learn more about our DCT Network.
Choosing Decentralized Clinical Trials
As the clinical landscape continues to evolve, the use of DCT solutions increases, keeping research moving forward and ensuring safety of clinical trials and patients.
DCT Therapeutic Expertise
Our therapeutic expertise spans the full research and development spectrum of indications, including rare disease, hematology/oncology and women’s health.
Why PPD Digital and Decentralized Solutions
PPD expertise supports every stage of the drug development process, helping you pivot to a digital-based trial approach.
“We offer a unique set of flexible solutions across the entire digital and decentralized trial spectrum. All of which are carefully designed to increase patient access to clinical trials and achieve a wide set of benefits from increase patient diversity and patient experience to enhancements in data quality and cost efficiencies for our customers.”
Digital Innovation & Implementation
How can PPD Digital help you reach more patients?